Sage Science
Generated 5/9/2026
Executive Summary
Sage Science is a US-based biotechnology company that develops automated instruments and consumables for DNA sample preparation and size selection, primarily for next-generation sequencing (NGS) workflows. Founded in 1999 and headquartered in Beverly, Massachusetts, the company has established a niche in enabling high-quality library construction for short-read, long-read, and linked-read sequencing platforms. Sage Science's product portfolio addresses critical bottlenecks in NGS sample prep, offering solutions that improve efficiency and accuracy for genomics research. With a focus on automation and size selection, the company serves academic, clinical, and commercial laboratories worldwide. Despite being a smaller player in a competitive market, Sage Science benefits from the growing demand for NGS-based applications in research and diagnostics. The company's long history and dedicated product focus position it as a reliable partner for genomics workflows, though its growth trajectory remains tied to broader NGS market trends and technological advancements.
Upcoming Catalysts (preview)
- Q4 2026Launch of next-generation size selection platform65% success
- TBDStrategic collaboration with major sequencing platform provider50% success
- Q1 2027Release of updated product line targeting liquid biopsy applications55% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)